Pregnancy-Associated Plasma Protein A (PAPP-A) is a protein used in first trimester screening tests. It is used to assess the risk that the fetus a pregnant woman is carrying has a chromosomal abnormality such as Down syndrome (trisomy 21) or Edwards syndrome (trisomy 18).
In first trimester screening it is used in conjunction with hCG or Free beta hCG as well as other diagnostic tests such as nuchal translucency. It offers the benefit of Down syndrome prediction (as a probability factor) earlier in the pregnancy but first trimester screening does not assess risk of of neural tube defects, such as spina bifida.
Please see Monobind's Triple Screen VAST assay for second trimester screening product.
Enzyme Immunoassay, Chemiluminescence
Sandwich Assay, Streptavidin-Coated Plate
0, 0.64, 1.6, 3.2, 9.6, 32 µg/ml
September 17, 2018 Notice
Previous version of PAPP-A (7925-300 and 7975-300) have been replaced with new product which uses mass units, has a shorter procedure and overall offers a more compelling product with better correlation to market-preferred methods. See new product and new IFUs.